top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Marine Compounds and Cancer 2020
Marine Compounds and Cancer 2020
Autore Honecker Friedemann
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Descrizione fisica 1 electronic resource (480 p.)
Soggetto topico Medicine
Soggetto non controllato apoptosis
fucoidan
hepatocellular carcinoma
reactive oxygen species
3-alkylpyridinium polymers
nicotine
nicotinic acetylcholine receptor
non-small cell lung carcinoma
melanoma
sinulariolide
proteomic
mitochondria
caspase cascade
marine fungus
sediment
anthranilic acid
Penicillium paneum
cytotoxicity
dibromotyrosine
mitochondrial dysfunction
oxidative stress
topoisomerase
epigonal organ
bonnethead shark
Jurkat
tumor cell line
hippuristanol
PEL
AP-1
STAT3
Akt
colorectal cancer
marine mollusc
brominated indoles
shrimp
chemoprevention
fatty acids
carotenoids
cancer
nanoparticle
osteosarcoma
lung metastasis
elisidepsin
lipid rafts
hydroxylated lipids
fatty acid 2-hydroxylase
cooperative binding
membrane permeabilization
marine organisms
polysaccharides
anticancer
anticarcinogenic
mechanisms of action
fumigaclavine C
anti-proliferation
mitochondrial pathway
anti-cancer
anti-proliferative
carotenoid
cell cycle arrest
fucoxanthin
azoxymethane
bioactive natural product
isatin
in vivo model
Marthasterias glacialis L.
palmitic acid
ER-stress
CHOP
Antibody Drug Conjugates (ADCs)
marine antitumor agents
clinical trials
approved antitumor agents
AD0157
angiogenesis
marine drug
pyrrolidinedione
secondary metabolites
cancer preventive
chemopreventive
trabectedin
plitidepsin
tumor-associated macrophages
tumor microenvironment
preclinical
anticancer immunity
antiangiogenesis
fascaplysin
cyclin-dependent kinase
small cell lung cancer
camptothecin
poly(ADP-ribose)-polymerase inhibitor
breast cancer
seaweed
therapeutic compounds
autophagy
marine drugs
autophagy inhibitors
autophagy inducers
macrolide
programmed cell death
energy stress
araguspongine C
c-Met
HER2
gemcitabine
pazopanib
phase I
safety
soft tissue sarcoma
pachastrissamine
jaspine B
carbocyclic analogue
sphingosine kinase inhibitor
molecular modeling
ET-743
DNA minor groove binder
soft tissue sarcoma
chemotherapy
bis (2,3-dibromo-4,5-dihydroxy-phenyl)-methane (BDDPM)
anti-metastatic activity
cell adhesion
β1-integrin
FAK
BEL-7402 cell
triterpene glycosides
sea cucumbers
antitumor activities
arrest of cell cycle
antibacterial
marangucyclines
deep-sea
Streptomyces sp. SCSIO 11594
LS-1
SNU-C5/5-FU
TGF-β signaling
carcinoembryonic antigen
kalkitoxin
Moorea producens
mitochondria toxin
VEGF
angiogenesis inhibitor
hypoxia-inducible factor-1
HIF-1
Lyngbya majuscula
marine metabolites
SZ-685C
nonfunctioning pituitary adenomas
Ecklonia cava
phlorotannins
dieckol
migration
sipholenol A
ABC transporter
multidrug resistance
P-gp/ABCB1
BCRP/ABCG2
MRP1/ABCC1
marine natural products
glioblastoma
xyloketal B
proliferation
TRPM7
marine compound
ribosomal protein genes
snoRNA
FAU
RPS30
SNORA62
evolution
Porifera
Penicillium brevicompactum
Brevianamide
Mycochromenic acid derivative
antifouling
Caribbean sponge
plakortide
endoperoxide
leukemia
multi-drug resistant leukemia
Sarcophyton ehrenbergi
soft coral
terpenes
cembranoids
cytotoxic activity
molecular docking
uveal melanoma
oxidative stress
virtual screening
Topo I inhibitor
low toxic
natural product
Ulva fasciata
selenium-containing polysaccharide-protein complex
pseudopterosin
NF-κB
p65
inflammation
cytokine release
IL-6
TNFα
MCP-1
glucocorticoid receptor
paulomycins
Micromonospora
antitumor
Cantabrian Sea-derived actinobacteria
puupehenones
sponges
antiangiogenic
antitumoral
porifera/sponge
cancer genes
molecular oncology
bromophenol
molecular mechanisms
cell cycle
PI3K/Akt
p38/ERK
ROS
human lung cancer
glycosaminoglycans
antiproliferative
heparan sulphate
gliotoxin
NSCLC
adriamycin resistance
Sepia ink polysaccharides
antitumour
chemosensitization
anticoagulation
sea anemone
drug discovery
endothelial cells
RGD motif
kunitz type inhibitor
prostate cancer
antioxidant
natural marine compounds
marine biotechnology
microalgae
marine sponges
Aeroplysinin
Isofistularin
pheochromocytoma and paraganglioma
metastasis
cancer progression
cell adhesion molecules
integrin β1
hypoxia
phycocyanin
non-small cell lung cancer
NF-κB signaling
marine-derived drugs
bioanalysis
chromatography
manzamine A
epithelial-mesenchymal transition
lung cancer
circulating tumor cells
signal transduction
cisplatin
Lampetra morii
buccal gland
cystatin F
anti-angiogenesis
cystatin superfamily
Antimicrobial peptide (AMP)
Tilapia piscidin 4 (TP4)
non-small cell lung cancer (NSCLC)
itampolin A
FBDD
p38α
novel inhibitor
tetracenomycin X
cyclin D1
proteasomal degradation
p38
c-JUN
λ-carrageenan
heparanase
anticoagulant
depolymerisation
cell migration
Aspergillus
naphthopyrones
endophytic fungus
Leathesia nana
mangrove-derived actinomycete
ansamycins
divergolides
apoptosis-inducing activity
actinomycin
EMT
invasion
low molecular weight fucoidan extract
N-Ras
neuroblastoma-rat sarcoma
Cancer
programmed cell death-ligand 1
programmed cell death-ligand 2
human sarcoma cell line (HT1080 cells)
human normal diploid fibroblast (TIG-1 cells)
chimera
chemical conjugation
anticancer agent
hybridization
α9-nicotinic acetylcholine receptors (nAChRs)
breast cancer cells
αO-conotoxin GeXIVA
targeted therapy
gorgonian
Leptogorgia
humulane sesquiterpenoids
anticancer activity
12-deacetyl-12-epi-scalaradial
HeLa cells
Nur77
MAPK/ERK pathway
Mycalin A
C15 acetogenins
synthetic analogues
antiproliferative activity
A375 and HeLa cell lines
polyoxygenated steroids
sponge
Haliclona gracilis
Thalassia testudinum
thalassiolin B
polyphenols
CYP1A1
benzo[a]pyrene
JNK1/2
natural products
synergism
A549 cells
cytoskeleton
P2X7 receptor
pollution
anti-angiogenic
gene expression
HSP90
inhibitor
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557339303321
Honecker Friedemann  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Marine Natural Products and Obesity
Marine Natural Products and Obesity
Autore Vasconcelos Vítor
Pubbl/distr/stampa MDPI - Multidisciplinary Digital Publishing Institute, 2019
Descrizione fisica 1 electronic resource (194 p.)
Soggetto non controllato natural compounds
anti-obesity drugs
high fat diet
Ishige okamurae
fat
zebrafish Nile red fat metabolism assay
physical exercise
JAK2-STAT3
metabolite profiling
obesity
chlorophyll derivatives
brown seaweed
Skate skin
PPAR?
marine alga
marine biodiscovery
skate skin
lipolytic
leptin
uncoupling protein 1
3T3-L1 cells
glucolipid metabolism disorder
nutrition
bioactivity
chitosan oligosaccharide
diphlorethohydroxycarmalol (DPHC)
nutraceuticals
whole small animal models
high-fat diet
adipocyte
dyslipidemia
bioactivity screening
peroxisome proliferator-activated receptor gamma
white adipose tissue
antiobesity
fatty liver disease
thermal proteome profiling
inflammation
cyanobacteria
Raja kenojei
Arthrospira maxima
cellularity
adipocytes
bioactive compound
collagen peptide
double-blind
bisabolane-related compounds
proliferation
fatty acid metabolism
cholesterol metabolism
collagen
randomized controlled trial
mechanisms of action
murine pre-adipocytes
adipogenesis
fucan
marine sponges
label-free quantitative proteomics
diabetes
body fat
ISBN 3-03921-192-7
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910346840903321
Vasconcelos Vítor  
MDPI - Multidisciplinary Digital Publishing Institute, 2019
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Recent Advances in Antibody Therapeutics
Recent Advances in Antibody Therapeutics
Autore Heo Yong-Seok
Pubbl/distr/stampa Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica 1 electronic resource (238 p.)
Soggetto topico Research & information: general
Chemistry
Soggetto non controllato interleukin 33
ST2 receptor
scFv
C2_2E12
bladder cancer
antibodies
immune checkpoint inhibitors
antibody-drug conjugates
sacituzumab govitecan
enfortumab vedotin
erdafitinib
cost-effectiveness
G protein-coupled receptor
membrane protein
antigen
therapeutic antibody
anti-angiogenesis
delta-like ligand
irinotecan
paclitaxel
VEGF
SARS-CoV-2
spike protein
receptor-binding domain
phage display
monoclonal antibody
cytomegalovirus
peptide/major histocompatibility complex class I complex
T-cell-receptor-like antibody
affinity maturation
yeast surface display
combinatorial antibody library
agonist antibody
cell fate
bispecific antibodies
bioassays
mechanisms of action
binding assays
potency assays
atherosclerosis
inflammation
antibody therapy
blood-brain barrier
antibody
pharmacokinetics
disposition
biochemical and physicochemical properties
Fc binding
receptor-mediated transcytosis
brain shuttle
molecular Trojan horse
transferrin
anti-cancer antibody
antibody engineering
biophysical properties
computational methods
research cell bank
antibody therapeutics
recombinant antibodies
intracellular antibodies
single-chain antibody fragment
nanobody
Human papillomaviruses
HPV oncoproteins
HPV-associated cancer
HPV cancer therapy
asthma
refractory asthma
biomarker
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910580204803321
Heo Yong-Seok  
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui